SFM
KYNB

Sphera Funds Management’s Kyntra Bio KYNB Stock Holding History

Sphera Funds Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,591
Closed -$1.84M – 113
2018
Q1 		$1.84M Sell
1,591
-3,200
-67% -$4.21M 0.28% 77
2017
Q4 		$5.68M Sell
4,791
-400
-8% -$502K 0.67% 33
2017
Q3 		$6.98M Sell
5,191
-1,437
-22% -$1.51M 1% 22
2017
Q2 		$5.35M Hold
6,628
– – 0.91% 27
2017
Q1 		$4.08M Buy
6,628
+400
+6% +$244K 0.8% 32
2016
Q4 		$3.33M Buy
6,228
+400
+7% +$200K 0.84% 34
2016
Q3 		$3.02M Buy
5,828
+2,400
+70% +$1.13M 0.49% 54
2016
Q2 		$1.41M Buy
+3,428
New +$1.57M 0.37% 69

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Sphera Funds Management's KYNB Position: Q2 2018 in Review

Sphera Funds Management sold out of Kyntra Bio (KYNB) in Q2 2018, closing a stake of 1,591 shares — an estimated $1.84M sold.

Sphera Funds Management first reported a position in KYNB in Q2 2016 and held it in 8 quarters. The position peaked at $6.98M in Q3 2017. 192 funds tracked by Wall St. Rank hold KYNB as of Q2 2018.

  • Sphera Funds Management reported no remaining Kyntra Bio position as of Q2 2018 after selling out during the quarter.
  • Sphera Funds Management sold 1,591 Kyntra Bio shares in Q2 2018, an estimated $1.84M.
  • Sphera Funds Management first reported a position in Kyntra Bio in Q2 2016 and held it in 8 quarters.
  • Sphera Funds Management's Kyntra Bio position peaked at $6.98M in Q3 2017.
  • 192 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2018.

Based on Sphera Funds Management's 13F filing for Q2 2018, filed 13 Aug 2018.